To Study the Prevalence of Neurological Diseases in the Primary Health Care System
DOI:
https://doi.org/10.51699/ijhsms.v2i1.956Keywords:
Chronic kidney disease (CKD), End-stage renal failure (ESRD), Nephrological diseasesAbstract
Chronic kidney disease (CKD) is a global public health problem that is often undiagnosed and untreated. CKD is a "silent" disease and remains unnoticed because it cannot be "felt". However, it affects many more people than we can imagine: 1 in 10 adults in the world has some form of kidney damage. However, up to 90% of those with CKD remain undetected. High blood pressure and diabetes are the main causes of CKD. Diabetes is projected to increase by 70% by 2025. Therefore, early detection and prevention of the progression of CKD in people with very high cardiovascular risk are extremely important tasks and goals for general practitioners/family doctors (GP/CB).). CKD is a progressive irreversible decrease in glomerular filtration rate (GFR). Unfortunately, most chronic nephropathies lack specific treatment, and they steadily progress to end-stage renal failure (ESRD). Progressive loss of renal function is common in kidney failure, regardless of the underlying cause of kidney disease.
Downloads
References
World Kidney Day. www.worldkidneyday.org (as of April 9, 2008).
Brenner B.M. and Anderson S. The relationship between filtration surface area, blood pressure and chronic kidney disease. Journal of Cardiovascular Pharmacology 1992; 19 (Supplement 6): S1–7.
Ots M., Pehter U. and Tamm A. Characteristics of progressive kidney disease. Clinic Chimica Acta 2000; 297:29-41.